Skip to main content
. Author manuscript; available in PMC: 2014 Feb 8.
Published in final edited form as: Cancer. 2008 Aug 15;113(4):847–853. doi: 10.1002/cncr.23621

Figure 2. SKINDEX-16 Itching Scores.

Figure 2

Serial SKINDEX-16 scores showed a few favorable effects with tetracycline, including better itching scores by week 4. In this figure the y-axis helps illustrate the percentage change in scores from baseline, and the x-axis shows time and the number of patients being evaluated at each time point. The median percent of baseline present at week 4 was 83% in tetracycline-treated patients and 50% in placebo-exposed patients with the higher median percent being more favorable (p=0.005).